Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › TX › Azle › NPI 1619955432
Physician

Hudman, Jennifer

Hudman, Jennifer was paid $2.62M by Medicaid between Aug 2020 and Sep 2024, across 46 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 23% of everything it billed.

33Billing provider infoHUDMAN, JENNIFER
AZLE, TX 76020
33aNPI1619955432assigned 01/03/2006
33bProvider typePediatrics Physician
28Total paid$2.62M
24GClaims125,332
24DCodes billed46
24AFirst – last monthAug 2020 – Sep 2024
Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#183 of 1,136
Median peer was paid$329K
This provider vs. median8.0×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20204,201$76K
202130,495$622K
202233,127$676K
202332,982$689K
2024incomplete24,527$557K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 23% 16,239 13,545 $597K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 13% 4,207 4,193 $335K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 12% 3,984 3,962 $308K
90460 Immunization administration through 18 years of age via any route, first or only component 11% 25,310 8,135 $277K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 8.7% 2,699 2,693 $229K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 6.4% 3,396 3,110 $166K
99429 4.9% 3,755 3,737 $127K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 4.4% 1,227 1,226 $114K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3.8% 7,242 3,404 $100K
92552 2.7% 4,059 4,048 $70K
96110 Developmental screening, with scoring and documentation, per standardized instrument 2.3% 9,087 9,060 $59K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 2.2% 4,291 4,072 $59K
34 more codes
87811 Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) 1.5% 1,006 $40K
90677 1.4% 852 $37K
99381 1.3% 403 $33K
90461 1.1% 6,529 $30K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 974 $12K
99383 <1% 82 $8K
99382 <1% 54 $5K
92551 <1% 1,602 $4K
87807 <1% 229 $2K
99203 Doctor's office visit, new patient (routine) <1% 38 $2K
G8510 Screening for depression is documented as negative, a follow-up plan is not required <1% 259 $2K
96160 <1% 1,447 $1K
81002 <1% 217 $619.04
99000 <1% 55 $561.60
90734 <1% 135 $144.48
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 169 $103.31
90651 0% 282 $0.00
90744 0% 1,702 $0.00
90680 0% 2,349 $0.00
90716 0% 486 $0.00
90698 0% 441 $0.00
90686 0% 345 $0.00
90619 0% 72 $0.00
90700 0% 3,462 $0.00
90707 0% 483 $0.00
90713 0% 2,544 $0.00
90670 0% 2,650 $0.00
99173 0% 5,664 $0.00
90715 0% 117 $0.00
90648 0% 2,652 $0.00
90710 0% 397 $0.00
90685 0% 416 $0.00
90672 0% 110 $0.00
90633 0% 1,613 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.